共 50 条
- [24] Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial LANCET, 2021, 397 (10293): : 2467 - 2475
- [28] Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (08):